Related Experiment Video
Updated: Jul 13, 2026
14:43
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Subgroup analysis in obstetrics clinical trials.
1Division of Epidemiology, Statistics, and Prevention Research, National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
American Journal of Obstetrics and Gynecology
|August 11, 2007
Summary
Subgroup analysis in clinical trials requires careful interpretation. Valid subgroup findings depend on pre-randomization characteristics and formal interaction tests, not just p-values, to avoid spurious results.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Evidence-Based Medicine
Background:
- Clinical trials typically report aggregate results, limiting personalized treatment decisions.
- Clinicians desire subgroup analyses based on patient characteristics for tailored therapies.
- Subgroup analyses are frequently performed and interpreted incorrectly, even when valid.
Purpose of the Study:
- To clarify the correct methodology for subgroup analysis in clinical trials.
- To highlight common misinterpretations of subgroup data.
- To establish criteria for valid subgroup findings.
Main Methods:
- Discusses the validity of subgroups defined by characteristics determined at or before randomization.
- Contrasts incorrect use of probability values for subgroup effectiveness with formal tests for interaction.
- Emphasizes the importance of a priori subgroup definition and rationale.
Main Results:
- Most observed subgroup differences in treatment effectiveness are spurious, even when analyzed correctly.
- Formal tests for interaction are the correct statistical method for assessing subgroup effects.
- Subgroup findings require strong rationale and replication for validation.
Conclusions:
- Subgroup analyses must use pre-specified subgroups and interaction tests for validity.
- Interpreting subgroup differences requires caution due to the high likelihood of spurious findings.
- Replication and strong a priori rationale are crucial for confirming subgroup treatment effects.
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:20Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...